About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Signup For Free
EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet AMD
EyePoint Pharmaceuticals announced the completion of enrollment for its Phase 3 LUCIA trial evaluating DURAVYU™ for wet age-related macular degenerati...
Copyright © 2025. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet AMD